Danaher announces chief executive transition

By The Science Advisory Board staff writers

May 7, 2020 -- Danaher announced on May 6 that Executive Vice President Rainer Blair will succeed Thomas Joyce Jr. as president and CEO when Joyce retires on September 1.

Joyce has served as Danaher's president and CEO since 2014 and joined the company in 1989. Blair has led Danaher's life sciences segment, growing annual revenues from $2.4 billion in 2015 to about $10 billion this year. Blair joined Danaher in 2010.

In other news, Danaher reported financial results for the first quarter of 2020 (end-April 3). The company posted revenues of $4.343 billion, up 3% from sales of $4.220 billion in the first quarter of 2019. The company posted net income of $595.1 million, compared with earnings of $333.8 million the same period the year before.

GE BioPharma sale to Danaher is complete
The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
FTC greenlights $20B GE-Danaher deal
Following an agreement with the U.S. Federal Trade Commission (FTC), GE Healthcare Life Sciences is moving forward with the sale of its GE Biopharma business...

Copyright © 2020 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter